Lyell Immunopharma, Inc.
LYEL
Revenue
15.00k
▲7.00k▲87.50%
3 Months ChangeAssets
407.97M
▲22.51M▲5.84%
3 Months ChangeLiabilities
78.84M
▼-7.69M▼-8.88%
3 Months ChangeFree Cash Flow
-54.98M
▼-12.94M▼-30.77%
12 Months ChangeRevenue/Cost Of Revenue
Loading...
Net Profit/Loss
Loading...
Assets/Liabilities
Loading...
Cash Flows
Loading...
Loading...
Loading...
Recent Quarterly and Annual Filings
2026-03-09
Form 8-K
ID: 0001193125-26-097615
2025-12-08
Form 8-K
ID: 0001193125-25-310469
2025-12-05
Form 8-K
ID: 0001193125-25-309621
2025-11-12
Form 10-Q
ID: 0001628280-25-051619
2025-11-12
Form 8-K
ID: 0001628280-25-051603
2025-11-10
Form 8-K
ID: 0001193125-25-273269
2025-11-03
Form 8-K
ID: 0001193125-25-261753
2025-09-16
Form 8-K
ID: 0001193125-25-205020
2025-08-12
Form 10-Q
ID: 0001806952-25-000008
2025-08-12
Form 8-K
ID: 0001806952-25-000007